Search research articles
Contact Us
Filters
Showing results (111-120 of 314) with videos related to
Page
of 32
Sort By:
Chinese Clinical Oncology
|
June 13, 2021
The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results
Lauren S Singer, Alexander Z Feldman, Robin A Buerki, et al.
Nature Reviews. Clinical Oncology
|
June 18, 2014
European perspective for effective cancer drug development
Denis Lacombe, Sabine Tejpar, Roberto Salgado, et al.
Neuro-Oncology Advances
|
December 15, 2025
Pediatric H3 K27-altered diffuse midline gliomas may consist of two clinically relevant subsets based on patient age and molecular genetic profile
Yufan Yang, Nitin Wadhwani, Yuki Aoi, et al.
Journal of Neuro-Oncology
|
November 12, 2018
Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod
Rimas V Lukas, Csaba Juhász, Derek A Wainwright, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
May 18, 2005
Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC
Edgardo Pezzetta, Roger Stupp, Abderrahim Zouhair, et al.
Cancer Chemotherapy and Pharmacology
|
July 1, 2008
A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites
Andrea Kuemmerle, Laurent A Decosterd, Thierry Buclin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 8, 2012
Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: the digital individual case review
Alysa Fairchild, Damien C Weber, Raquel Bar-Deroma, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 28, 2014
Addition of lomustine for bevacizumab-refractory recurrent glioblastoma
Michaela Tonder, Günter Eisele, Tobias Weiss, et al.
Acta Neuropathologica
|
September 24, 2010
Molecular diagnostics of gliomas: the clinical perspective
Ghazaleh Tabatabai, Roger Stupp, Martin J van den Bent, et al.
Cancer Treatment Reviews
|
June 23, 2012
Optimal management of elderly patients with glioblastoma
Normand Laperriere, Michael Weller, Roger Stupp, et al.
Page
of 32
Search research articles
Search
Showing results (111-120 of 314) with videos related to
Sort By:
Page
of 32
Chinese Clinical Oncology
|
June 13, 2021
The impact of the molecular classification of glioblastoma on the interpretation of therapeutic clinical trial results
Lauren S Singer, Alexander Z Feldman, Robin A Buerki, et al.
Nature Reviews. Clinical Oncology
|
June 18, 2014
European perspective for effective cancer drug development
Denis Lacombe, Sabine Tejpar, Roberto Salgado, et al.
Neuro-Oncology Advances
|
December 15, 2025
Pediatric H3 K27-altered diffuse midline gliomas may consist of two clinically relevant subsets based on patient age and molecular genetic profile
Yufan Yang, Nitin Wadhwani, Yuki Aoi, et al.
Journal of Neuro-Oncology
|
November 12, 2018
Imaging tryptophan uptake with positron emission tomography in glioblastoma patients treated with indoximod
Rimas V Lukas, Csaba Juhász, Derek A Wainwright, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
May 18, 2005
Comparison of neoadjuvant cisplatin-based chemotherapy versus radiochemotherapy followed by resection for stage III (N2) NSCLC
Edgardo Pezzetta, Roger Stupp, Abderrahim Zouhair, et al.
Cancer Chemotherapy and Pharmacology
|
July 1, 2008
A phase I pharmacokinetic study of hypoxic abdominal stop-flow perfusion with gemcitabine in patients with advanced pancreatic cancer and refractory malignant ascites
Andrea Kuemmerle, Laurent A Decosterd, Thierry Buclin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 8, 2012
Quality assurance in the EORTC 22033-26033/CE5 phase III randomized trial for low grade glioma: the digital individual case review
Alysa Fairchild, Damien C Weber, Raquel Bar-Deroma, et al.
Acta Oncologica (Stockholm, Sweden)
|
May 28, 2014
Addition of lomustine for bevacizumab-refractory recurrent glioblastoma
Michaela Tonder, Günter Eisele, Tobias Weiss, et al.
Acta Neuropathologica
|
September 24, 2010
Molecular diagnostics of gliomas: the clinical perspective
Ghazaleh Tabatabai, Roger Stupp, Martin J van den Bent, et al.
Cancer Treatment Reviews
|
June 23, 2012
Optimal management of elderly patients with glioblastoma
Normand Laperriere, Michael Weller, Roger Stupp, et al.
Page
of 32